- McNeil unveils 'Smiling it Forward' campaign in support of Tylenol
- Energizer Holdings to acquire feminine hygiene business from J&J Family of Consumer Cos.
- Prestige Brands solution to pediatric overdosing — unique squeezable, single-dose APAP packet
- Cardinal Health invites independent pharmacy owners to ‘discover new horizons’ at RBC 2013
- J&J to add red warning label to Tylenol in effort to raise awareness on appropriate dosing
NEW YORK — It seems that Tylenol Cold & Flu Severe caplets are making their way back to store shelves, according to published reports.
According to several reports, McNeil Consumer Healthcare spokeswoman Bonnie Jacobs confirmed that the product, which is designated for adult use, will begin shipping this week.
McNeil Consumer Healthcare, a Johnson & Johnson subsidiary, recalled several lots of Tylenol products due to reports of uncharacteristic odor, which was linked to the presence of trace amounts of a chemical known as 2,4,6-tribromoanisole (TBA).
Back in February, J&J executives said McNeil Consumer’s absence from cough-cold and analgesic aisles, including several pediatric formulations, would extend into the fourth quarter.